CEO of Prana Therapeutics
Brent A. Reynolds, Ph.D. attended the University of Calgary where he received his M.Sc. and Ph.D. in 1989and 1994, respectively. Reynolds has more than 80 publications including papers in Science, Nature and Cell with several manuscripts receiving over 1000 citations. In addition, he is an inventor on 19 granted US patents and numerous patent applications. Reynolds is currently the CEO of Prana Therapeutics, Inc., a Professor in the Dept. of Neurosurgery at theUniversity of Florida, Adjunct Professor at the University of New South Wales, Sydney, Australia, an HonoraryProfessor at the Queensland Brain Institute, Australia and Program Director for StepAhead, Australia. NIH,NHMRC and numerous foundations have funded his lab.